Upgrade to SI Premium - Free Trial

Novocure (NVCR)

15.63 -0.08 (0.51%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Form 8-K NovoCure Ltd For: Oct 01 October 1, 2026 9:01 AM - SEC Filing Novocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer October 1, 2026 9:01 AM - BizWire Novocure to Report Third Quarter 2026 Financial Results October 1, 2026 7:00 AM - BizWire NovoCure reports data breach affecting over 1,400 patient records September 1, 2026 7:03 AM - StreetInsider NovoCure Ltd. (NVCR) PT Raised to $20 at Wedbush July 24, 2026 7:47 AM - StreetInsider NovoCure Ltd. (NVCR) PT Lowered to $32 at H.C. Wainwright July 24, 2026 7:31 AM - StreetInsider NovoCure Ltd. (NVCR) PT Raised to $20 at Wells Fargo July 24, 2026 6:29 AM - StreetInsider Form 144 NovoCure Ltd Filed by: Leupin Nicolas July 23, 2026 4:22 PM - SEC Filing Novocure (NVCR) Tops Q2 EPS by 20c; offers guidance July 23, 2026 7:02 AM - StreetInsider Form 8-K NovoCure Ltd For: Jul 23 July 23, 2026 7:00 AM - SEC Filing Novocure Reports Second Quarter 2026 Financial Results July 23, 2026 7:00 AM - BizWire Form 10-Q NovoCure Ltd For: Jun 30 July 23, 2026 7:00 AM - SEC Filing Full Article List